The COMPARE Initiative is an international not-for-profit research collaboration working towards an international consensus on definitions and standardised outcome measures for therapeutic trials and epidemiological studies in Paediatric Endocrinology.
WHAT DOES COMPARE STAND FOR?
COMPARE is an acronym for Core Outcome Measures in PediAtRic Endocrinology.
WHO ARE WE?
The outcomes are developed based on shared priorities between patients, families and caregivers, clinicians, researchers, policy makers and other relevant stakeholders. You can find out more information about who is involved under each project e.g. COMPARE-Bone.
The executive group which oversees all the various projects is composed of:
- Professor Geoffrey Ambler
- Ms Camilla Hanson
- Dr Richard McGee (founder and chair)
- Dr Shubha Srinivasan
- Professor Allison Tong
The compare bone executive group consists of:
- Dr Andrew Biggin
- Dr Richard McGee
- Professor Craig Munns
- Associate Professor Verity Pacey
- Dr Myra Poon
- Ms Christie Wall
WHAT IS AN OUTCOME?
When conducting research the effects of an intervention e.g. a medication are assessed by looking at how this changes an ‘outcome’. An outcome is something that can be measured and is related in some way to a health condition or treatment.
WHERE IS COMPARE BASED?
Institute of Endocrinology and Diabetes,
The Children’s Hospital at Westmead,
Locked Bag 4001, Westmead, NSW, 2145, Australia.
WHEN DID COMPARE BEGIN?
The COMPARE Initiative began in February 2017. It is registered with the COMET Initiative here:
ARE THERE OTHER GROUPS LIKE COMPARE?
Yes, there are groups, which co-ordinate the development of core outcome measures in other areas. For example: